In a 71-year-old woman with knee pain, should corticosteroid therapy be continued for more than four months?

No, corticosteroid therapy should NOT be continued for more than 4 months in a 71-year-old woman with knee pain.

Intra-articular corticosteroid injections should be limited to 3-4 injections per year (approximately every 3 months), providing short-term relief of 2-4 weeks, and are not intended for continuous long-term use beyond this timeframe 1.

Guideline-Based Limitations

The 2021 EULAR recommendations explicitly state that "a general accepted rule, though based on no research evidence, is to avoid more than 3-4 GC injections in the same joint per year" 1. This translates to a maximum treatment duration of approximately 12 months with quarterly injections, not continuous therapy beyond 4 months.

The 2021 ESCEO/OARSI guidelines similarly position intra-articular corticosteroids as short-term interventions (2-4 weeks of benefit) for patients with persistent pain after first-line treatments fail 2. These are rescue therapies, not maintenance treatments.

Evidence on Duration and Safety

Short-Term vs Long-Term Efficacy

• Proven benefit: 2-4 weeks post-injection 2
• Questionable benefit: Beyond 6 weeks 2
• One high-quality RCT showed symptom improvement with injections every 3 months for 2 years without cartilage damage 3, but another RCT demonstrated greater cartilage volume loss with repeated corticosteroid use 1

Critical Safety Concerns at 4+ Months

Chondrotoxicity: Recent evidence (2026) indicates that long-term use should be avoided to prevent chondrotoxicity and further osteoarthritis progression 4. This directly contradicts extended use beyond the guideline-recommended intervals.

Age-Specific Risks: At 71 years old, this patient faces heightened risks:

• Systemic corticosteroid effects accumulate with repeated injections
• Increased cardiovascular and gastrointestinal adverse event risk with age 2
• Bone mineral density reduction and fracture risk 5, 6
• Adrenal suppression 6
• Hyperglycemia (particularly concerning if diabetic) 1

Practical Algorithm for This Patient

If currently at 4 months of corticosteroid therapy:

1. Stop further injections - the risk-benefit ratio becomes unfavorable
2. Reassess the treatment plan:
   • Optimize core treatments: weight loss, exercise, physical therapy 2
   • Consider topical NSAIDs (safer in elderly) 2
   • Evaluate for intra-articular hyaluronic acid as alternative 2
   • Short-term oral NSAIDs (lowest dose, shortest duration) with PPI if no cardiovascular contraindications 2
3. Screen for surgical candidacy if conservative measures fail

If considering repeat injections:

• Maximum 3-4 injections per year (every 3 months minimum) 1
• Each injection decision should be individualized based on response to previous injection
• Document benefit duration from each injection
• If benefit lasts <2 weeks, reconsider the approach entirely

Common Pitfalls to Avoid

• Do not use corticosteroids as chronic maintenance therapy - they are rescue interventions
• Do not inject more frequently than every 3 months in the same joint 1
• Do not continue if minimal benefit - obesity and advanced arthritis (Kellgren-Lawrence grade 3-4) predict poor response 7
• Do not ignore systemic effects - intra-articular injections cause systemic absorption with metabolic consequences 6

The 2025 multisociety guidelines confirm that IACS provides "short-term pain relief from a few weeks to a few months" with significant adverse events including cartilage damage, bone mineral density reduction, and metabolic effects 6. Continuing beyond 4 months of therapy contradicts the intended short-term, intermittent use pattern supported by all major guidelines.